isospaglumic acid has been researched along with Extravascular Hemolysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feuillard, J; Goldschmidt, P; Kazatchkine, MD; Maillet, F; Weiss, L | 1 |
| David, B; Etievant, M; Leluc, B | 1 |
2 other study(ies) available for isospaglumic acid and Extravascular Hemolysis
| Article | Year |
|---|---|
Comparative study of in vitro inhibition of activation of the classical and alternative pathways of human complement by the magnesium and sodium salts of the anti-inflammatory peptide N-acetyl-aspartyl-glutamic acid (NAAGA).
Topics: Animals; Complement C3; Complement C3-C5 Convertases; Complement Inactivator Proteins; Complement Pathway, Alternative; Complement Pathway, Classical; Dipeptides; Hemolysis; Humans; Rabbits; Sheep | 1991 |
In vitro inhibition of the classical and alternate pathways of activation of human complement by N acetyl aspartyl glutamic acid (NAAGA).
Topics: Complement Activation; Complement C3; Complement C3a; Complement C5; Complement C5a; Complement Pathway, Alternative; Complement Pathway, Classical; Dipeptides; Hemolysis; Humans; In Vitro Techniques | 1988 |